ARBLI ™ is the first and only oral liquid formulation of losartan approved by the U.S. FDA. ARBLI ™ comes in a 165 mL bottle as a peppermint flavored suspension that does not require refrigeration, ...
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2025 and reaffirmed its full-year 2026 financial guidance (1) provided on December 16, 2025. EXECUTIVE COMMENTARY ...
News-Medical.Net on MSN
Targeted PICU rounds reduce the rate of healthcare-associated conditions
Rounds focused on critically ill pediatric patients at the greatest risk for developing healthcare-associated conditions (HACs) reduced the rate of specific HACs by nearly 50% at a Colorado hospital, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results